Navigation Links
Watch Harvey up his Game with Hormone Therapy
Date:11/19/2012

MIAMI, Nov. 19, 2012 /PRNewswire/ -- AAG Health & Wellness, a recognized leader in hormone replacement therapy for men, is excited to announce the release of a video that follows the trials and tribulations of a client over the course of his first six month hormone treatment plan.

(Photo: http://photos.prnewswire.com/prnh/20121119/FL15499 )

Watch: Harvey's story. His hormone therapy experience.

The video's subject is a 61 year Miami Beach executive named Harvey who turns to AAG Health for help to get his busy life back on track. After years of declining energy, loss of libido and lack of motivation, Harvey is determined to take action to improve his quality of life and regain peak performance.

"I just got to a point where I said enough is enough. I couldn't keep up with my kids, I wasn't getting results from my workouts, I wasn't paying enough attention to my business and I wanted to get back in the dating scene," explained Harvey, father of 3 children and recently divorced.

The video starts with Harvey going to AAG Health's Age Management center in Miami for his initial evaluation and then goes on to document his progress from month one through month six.

"This is a unique account of how an otherwise healthy man, who is experiencing issues associated with low hormones, reacts to a progressive hormone therapy program that incorporates exercise and good diet," says Frank Welch MD, one of Harvey's treating physicians at AAG Health.

"Harvey came to us wanting to get back the vitality and vigor he had so he could accomplish more. I think we certainly delivered what he was looking for." Dr. Welch continues, "We've treated thousands of men over the past ten years and we're delighted to showcase another success story in this video."


'/>"/>
SOURCE AAG Health & Wellness
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Metabolex Gout Program Recognized in Windhovers Top 10 Most Interesting Projects to Watch
2. POSITIVEID In Businessweek For Bid On U$5.7 Billion BIOWATCH Program
3. Astrix Technology Group Awarded Department of Homeland Security BioWatch Laboratory Staffing Contract
4. 3M Withdraws Blackmail Claims Against Harvey Boulter From New York Court
5. Data From Phase II Trial of Prolor Biotechs Long-acting Human Growth Hormone Presented at Endo 2012
6. PROLOR Biotech To Present Data On Its Long-Acting Human Growth Hormone At International NeuroEndocrine Meeting
7. PROLOR Biotech to Present Data on Its Long-Acting Human Growth Hormone at Pediatric Endocrinology Meeting
8. Gene Therapy - Technologies, Markets and Companies
9. Studies Assess Hydroxyurea Therapy and Pre-Operative Transfusions for Patients with Sickle Cell Disease
10. TrovaGene, Inc. Obtains Exclusive License to Novel Mutations Associated with Prognosis and Chemotherapy Response in Leukemia
11. Amsterdam Molecular Therapeutics Receives US Orphan Designation for Hemophilia B Gene Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... , Aug. 31, 2015  RXi Pharmaceuticals Corporation ... on discovering and developing innovative therapies primarily in ... that the 30-day review period following the filing ... ocular indications with the U.S. Food and Drug ... now active. Logo -  ...
(Date:8/31/2015)... SHANGHAI , Aug. 31, 2015  MicuRx ... antibiotics, today announced positive top-line results from the ... drug candidate MRX-I. MRX-I is an oral oxazolidinone ... MRSA and VRE, while offering physicians and patients ... currently available oxazolidinone agents. "These ...
(Date:8/31/2015)... LabStyle Innovations Corp. (OTCQB: DRIO), developer ... it recently closed a round of funding totaling ... support the global rollout and initial U.S. commercial ... management solution that includes novel software applications combined ... device, and for working capital purposes. The Dario ...
(Date:8/31/2015)... Grove, IL (PRWEB) , ... August 31, 2015 ... ... impurities (PGIs), as a high priority in the drug development approval process. Thus, ... , This year, Regis Technologies, Inc., a Chicago-based CMO, has been hosting ...
Breaking Biology Technology:RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 3RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 4MicuRX Reports Positive Top-Line Results In Phase 2 Clinical Trial For Novel Antibiotic MRX-I In Complicated Skin And Soft Tissue Infections 2LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 2LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 3LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 4Regis Shares Expert Advice on Impurities in Drug Development 2Regis Shares Expert Advice on Impurities in Drug Development 3
... Pearl Therapeutics announced,today that it has secured $8 ... Silicon Valley Bank, a member company of SVB Financial,Group ... will be drawn in two,tranches. , ... Oxford and SVB. They are,experienced and committed lenders ...
... 24 An investor group in Trinity,Biotech plc (Nasdaq: ... manufacturer of,diagnostic products, has petitioned the Office of the ... law provisions designed,to permit communication between shareholders and prospective ... filed asserts that Irish-based independent directors,Peter Coyne of Allied ...
... VITAS Innovative Hospice Care(R) announced,today that Christopher ... chief,information officer. In his new position, Rieder will ... to support the company,s,strategic direction. , ... of IT experience with global organizations,translating business objectives ...
Cached Biology Technology:Pearl Therapeutics Secures $8 Million in Debt Financing 2Pearl Therapeutics Secures $8 Million in Debt Financing 3VITAS Innovative Hospice Care(R) Names Christopher Rieder Senior Vice President and Chief Information Officer 2
(Date:8/5/2015)... Aug. 5, 2015 The biosensors market is ... applications, penetration into newer sectors, and development of devices ... biosensors space has seen the entry of multiple participants ... far. (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... Analysis of the Global Biosensors Market ( http://www.frost.com/nee9 ...
(Date:7/31/2015)... , 31 de julio de 2015 ... (ICG-10,  www.icg-10.org ) del 22 al 25 de octubre ... La conferencia celebra su décimo aniversario este ... convertido en una de las reuniones anuales más influyentes ... es una de las conferencias científicas más dinámicas, entusiastas ...
(Date:7/31/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market and creator of the Wocket® ... 62/198989 for ELECTRONIC CRYPTO-CURRENCY MANAGEMENT METHOD AND ... advance crypto-currencies such as Bitcoin into the consumer market ... to manage all payments.  The technology ...
Breaking Biology News(10 mins):Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4
... air pollutant that harms humans and plants. Both climate and ... Researchers at the University of Gothenburg, Sweden, have now shown ... risk of ozone damage to plants in northern and central ... risk of ozone damage to vegetation is mainly due to ...
... German . When a cell divides, the ... to the daughter cells. Researchers at the Friedrich Miescher Laboratory ... a model organism. In cooperation with researchers at the University ... Aurora enzymes, which were already recognized as important cellular tools ...
... of engineers and scientists at the University of British Columbia ... eye for controlled and on-demand release of drugs to treat ... leading cause of vision loss among patients with diabetes. The ... in the retina, which in its advanced stages can result ...
Cached Biology News:Climate change increases the risk of ozone damage to plants 2New tasks attributed to Aurora proteins in cell division 2New tasks attributed to Aurora proteins in cell division 3UBC researchers invent new drug delivery device to treat diabetes-related vision loss 2
... SAPK/JNK (Thr183/Tyr185) Antibody Kit Kit ... Catalog #9251, 200 ul SAPK/JNK (56G8) ... SAPK/JNK Cell Extracts, Catalog #9253, (4 ... Catalog #7074, 100 ul Anti-biotin IgG, ...
100 g monoclonal antibody which can immunocapture ~10 g of Complex IV from heart mitochondria. Also included are 2 mg of bovine heart mitochondria for control immunocapture....
Anti-gp120/160(SIV/mac239) Immunogen: gp120(SIV/mac239) protein (Genebank accession #M33262)...
Rabbit polyclonal to GPR56 ( Abpromise for all tested applications). entrezGeneID: 9289 SwissProtID: Q9Y653...
Biology Products: